Dear Editor:
Over the last five decades, there has been a revolution in cancer care. Multimodal management has had a great impact on cancer survival rates. Surgeons can no longer work in isolation and must be part of a multidisciplinary team. They must be more than just a technician and must understand the contributions made by other specialties and how this may impact on the type and timing of surgery. The technical side of surgery has also been transformed in the past few decades with advances in minimally invasive cancer surgery. At the same time, surgical trainees are faced with the difficult task of mastering a subject of unprecedented complexity, which is continuously and rapidly evolving. These advances require dedication and a significant commitment to continuous surgical education, in all its various forms, across Europe [1] .
In Europe, postgraduate and continuous medical/surgical education is provided by academic institutions, cancer centres, scientific societies (European Society for Medical Oncology (ESMO), European Society for Therapeutic Radiology and Oncology (ESTRO), European Society of Surgical Oncology (ESSO)), and scientific bodies (European Organisation for Research and Treatment of Cancer (EORTC), European School of Oncology (ESO)). ESO was founded in 1982; its mission is reflected in its motto 'Learning to Care', which stresses the concept of studying and learning and also caring for the patient in a global sense. ESSO was established in 1981 with a mission to support its members in advancing the science and practice of surgical oncology for the benefit of cancer patients through a range of activities including education, research and leadership in multidisciplinary care. Both organisations offer educational activities including courses, seminars, symposia, inside track conferences, global insight conferences and masterclasses. The masterclass in surgery is a unique educational event in collaboration between ESO and ESSO.
This key educational event carries the following characteristics: (i) it offers high-quality and up-to-date lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines, (ii) participants deliver case presentations within small groups and discuss them with faculty members and (iii) it is a multidisciplinary clinically oriented 5-day residential event in which participation is compulsory throughout the course.
An international faculty of more than 30 European distinguished academic experts including surgeons, medical oncologists, radiation oncologists and radiologists are involved in each of this rather intense educational programme. Most faculty members are well-known experts from prominent European universities or cancer centres.
The ideal masterclass candidate should fulfil the following criteria: (i) age between 30 and 40 years; (ii) at least 2-3 years experience in surgical oncology; (iii) involvement in scientific or research activities; (iv) fluency in English and (v) submission of an application form along with a letter of motivation, supporting letter from head of department or mentor, curriculum vitae with list of publications and abstract of a clinical case relating to one of the subjects of the masterclass. Around 60 participants are selected annually by a committee.
In colorectal cancer surgery, three and 12 March 2015 in Warsaw, Poland. The aim and objective of all three masterclasses were the participants to be able to answer the following questions based on the knowledge of total mesocolon and total mesorectal surgery: These masterclasses having high-quality faculty members produced plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines that concluded in important take-home messages. Workshop sessions in small groups were organised in areas of decisionmaking in complex cases. Furthermore, participants delivered case presentations within small groups and discussed these with the chairmen and faculty. The Accreditation Council of Oncology in Europe (ACOE) and the European Accreditation Council for Continuing Medical Education (EACCME) have acknowledged the quality of the scientific programme and its educational value. The ESO-ESSO Masterclass in Colorectal Cancer Surgery has been assigned 27 European Continuing Medical Education Credits (ECMEC).
The surgical masterclass has traditionally been a way in which surgeons can augment their technical skills and develop the proficiency needed to perform advanced surgical techniques [2] . Lewis et al. have demonstrated a significant increase in surgeons performing advanced surgical procedures after attendance at a surgical masterclass [3] . A questionnaire was sent to surgeons attending surgical masterclasses in laparoscopic bariatric and colorectal surgery. The questionnaire examined operative experience before attending the masterclass and the consequent adoption of techniques. There was a significant adoption of colorectal procedures, from 33 to 79 % (P .00011), and bariatric procedures, from 27 to 66 % (P .014), after attendance at the surgical master classes.
Masterclasses should be considered as a supplementary postgraduate or continuing medical education tool for European or non-European surgeons. They could also be seen as an additional complimentary educational service for those European countries where surgical oncology has not been officially recognised. The European Community Law aims to ensure that European member states mutually recognise the qualifications of doctors to facilitate freedom of movement of individuals within Europe [4] . As most European member states operate different courses and issue different qualifications, this has been quite difficult to achieve. Therefore, standardisation and harmonisation of training through masterclasses would undoubtedly facilitate such mobility and enable enhanced training opportunities within member states.
The main argument against a specialism of surgical oncology is that it would not be possible for a single surgeon to have the expertise to perform a full range of oncological procedures ranging from pancreaticoduodenectomy to breast reconstruction and oesophagogastrectomy to radical neck dissection. This is indeed the case and is a situation which will become more marked with further technological advances. However, within each sub-specialist area, there is much shared knowledge and expertise, and in many cases, cross-sharing of techniques and ideas between site-specific disciplines has much to offer. It is anticipated that the 'advanced surgical oncologist' will have a broad base of relevant knowledge that transcends site specialisation. This should be supplemented with a high level of advanced knowledge and technical expertise and experience in the practical conduct of the surgical procedures relevant to their main disease site of interest.
In conclusion, as a past participant in one of the colorectal masterclasses, I considered these events an effective way of teaching young surgeons advanced surgical techniques and multidisciplinary approach in surgical oncology. Results have demonstrated that there is significant adoption of advanced surgical techniques as a direct result of attending these classes. This has important consequence for the design of surgical training programmes. With adequate extensive resources and funding, attendees can receive ongoing education, supervision to ensure performance of operations and these masterclasses could even be used within national training programmes aiming to augment the delivery of skills and knowledge in surgical oncology.
